Smarter prophylaxis: How RHD testing protects patients and resources
The supply of anti-D immunoglobulin, a prophylactic cornerstone of maternal care, has come under...
In this case study, Dr. Papasavva describes her laboratory’s journey from traditional thalassemia testing to state-of-the-art NGS technology and what a difference this has made in their daily work.
Ebook
This ebook explores the critical need to modernize cystic fibrosis (CF) diagnostics by transitioning from traditional fixed-panel genetic testing to comprehensive NGS-based CFTR analysis. It highlights:
The genetic basis of CF and why full CFTR gene analysis is critical for accurate diagnosis and carrier screening.
Disparities in traditional testing methods and how NGS helps close diagnostic gaps in underrepresented populations.
NGS as a scalable, cost-effective approach that supports evolving clinical guidelines and real-world lab demands.
The supply of anti-D immunoglobulin, a prophylactic cornerstone of maternal care, has come under...
Read More
Over the past decade, there has been a wealth of research investigating the ideal approach to RHD...
Read More
Devyser is today announcing that its product for non-invasive fetal RHD testing has been granted...
Read More
Devyser is today announcing that the company’s clinical testing laboratory in Roswell in Atlanta,...
Read More